Advances in delivering small interfering RNAs to specific tissues may bring these nucleotides closer to reality as therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Francis C. Szoka (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: